22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract

Technical University of Munich20 enrolled

Overview

The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Subepithelial Tumors of the Upper Gastrointestinal Tract

Interventions

22-G Procore NeedleDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patient age 18 years and older 2. All patients with subepithelial tumors of the upper GI tract (maximum size: 3 cm) Exclusion Criteria: 1. Unable to obtain informed consent 2. ASA class 4 or 5 3. known pregnancy 4. contraindication endoscopy 5. contraindication for taking biopsies

Locations (1)

Klinikum rechts der Isar

München, Bavaria, Germany

RECRUITING

Outcomes

Primary Outcomes

diagnostic yield

Number of patients with adequate tissue sample (which allows definitive diagnosis)

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.